TV46017
TV46017-COPD-10046
Phase 1 small_molecule terminated
Quick answer
TV46017 for Chronic Obstructive Pulmonary Disease (COPD is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Chronic Obstructive Pulmonary Disease (COPD
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated